TotalMarketCap

Krystal Biotech

KRYSNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$9.815 B

$331.61 +1.32%

Close of 12 Oct 2026

As of 12 Oct 2026, Krystal Biotech (KRYS) has a market capitalization of $9.82B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$389.1M

#2025 by revenue

Earnings

$204.8M

#994 by earnings

Shares outstanding

29,598,836

Latest filing cover page

P/E ratio

47.9

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 159 →
  1. #13VaxcytePCVX$10.6B
  2. #14Twist BioscienceTWST$10.6B
  3. #15Krystal BiotechKRYS$9.82B
  4. #16QiagenQGEN$9.35B
  5. #17Kymera TherapeuticsKYMR$9.35B

What if Krystal Biotech were worth as much as…

Open the what-if tool →

Gold $29.0T

$980,601.29

Per share 2,957× higher

Bitcoin $1.66T

$56,184.01

Per share 169× higher

Nvidia $5.53T

$186,684.64

Per share 563× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Krystal Biotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 13 Oct 2026. Read the methodology.